Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

  1. Siegel, D.S.
  2. Dimopoulos, M.A.
  3. Ludwig, H.
  4. Facon, T.
  5. Goldschmidt, H.
  6. Jakubowiak, A.
  7. San-Miguel, J.
  8. Obreja, M.
  9. Blaedel, J.
  10. Stewart, A.K.
Revue:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Année de publication: 2018

Volumen: 36

Número: 8

Pages: 728-734

Type: Article

DOI: 10.1200/JCO.2017.76.5032 GOOGLE SCHOLAR

Objectifs de Développement Durable